Europe — EMA

Olmesartan E Idroclorotiazide Eg (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxil, the active ingredient in Olmesartan E Idroclorotiazide Eg, is a angiotensin II receptor blocker presented as a oral tablet for hypertension management in adult patients.

Olmesartan Medoxomil, Hydrochlorothiazide

Request sourcing

Pack/s

What is Olmesartan Medoxomil, Hydrochlorothiazide?

Olmesartan medoxil, the active ingredient in Olmesartan E Idroclorotiazide Eg, is a angiotensin II receptor blocker presented as a oral tablet for hypertension management in adult patients. It combines olmesartan medoxil with hydrochlorothiazide to address high blood pressure and fluid retention.

GNH USA supplies Olmesartan E Idroclorotiazide Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Olmesartan Medoxomil, Hydrochlorothiazide used for?

Olmesartan E Idroclorotiazide Eg is an antihypertensive agent that acts on the renin‑angiotensin‑aldosterone system to control t t t. - Hypertension: It makes ...

What are the side effects of Olmesartan Medoxomil, Hydrochlorothiazide?

Common ...

What precautions apply to Olmesartan Medoxomil, Hydrochlorothiazide?

...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →